Inovio Pharmaceuticals, Inc. (INO)
NASDAQ · Healthcare
Inovio Pharmaceuticals, Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 65,343 | 217,756 | 832,010 | 10.3M | 1.8M | 7.4M | 4.1M | 30.5M | 42.2M | 35.4M | 40.6M | 10.5M | 13.5M | 4.1M | 9.8M | 6.1M | 9.1M |
| Gross Profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profitability | |||||||||||||||||
| Operating Income | -86.8M | -112.4M | -143.9M | -267.6M | -301.2M | -124.1M | -111.1M | -94.1M | -83.6M | -76.2M | -34.3M | -39.5M | -19.5M | -23.5M | -21.6M | -19.2M | -14.0M |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | -84.9M | -107.3M | -135.1M | -279.8M | -303.7M | -166.4M | -119.4M | -97.0M | -88.2M | -73.7M | -29.2M | -36.1M | -66.0M | -19.7M | -15.3M | -17.6M | -24.4M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 47M | 27M | 22M | 20M | 17M | 155M | 99M | 93M | 82M | 73M | 68M | 59M | 46M | 34M | 135M | 105M | — |
Inovio Pharmaceuticals, Inc. Income Statement — FAQ
Inovio Pharmaceuticals, Inc. (INO) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INO's income statement history?
The chart and table above show Inovio Pharmaceuticals, Inc.'s income statement by year and by quarter, including the growth rate.